A detailed history of Fora Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fora Capital, LLC holds 44,590 shares of NVO stock, worth $3.79 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
44,590
Holding current value
$3.79 Million
% of portfolio
0.67%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $5.31 Million - $6.48 Million
44,590 New
44,590 $5.31 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $2.47 Million - $2.73 Million
15,824 Added 135.78%
27,478 $4.45 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $207,112 - $249,054
1,565 Added 15.51%
11,654 $1.85 Million
Q4 2022

Feb 08, 2023

SELL
$102.55 - $135.33 $403,226 - $532,117
-3,932 Reduced 28.04%
10,089 $1.37 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $1.34 Million - $1.64 Million
14,021 New
14,021 $1.4 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $1.2 Million - $1.47 Million
-12,563 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $1.06 Million - $1.34 Million
12,563 New
12,563 $1.21 Million
Q4 2020

Feb 12, 2021

SELL
$63.89 - $73.8 $156,977 - $181,326
-2,457 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $164,574 - $181,448
-2,584 Reduced 51.26%
2,457 $171 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $1.22 Million - $1.41 Million
-20,765 Reduced 80.47%
5,041 $330 Million
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $151,990 - $199,068
3,073 Added 13.52%
25,806 $1.55 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $1.13 Million - $1.32 Million
22,733 New
22,733 $1.32 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.